Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Gilbert

Showing results (721-730 of 869) with videos related to

Pageof 87
Sort By:
Neuromuscular Disorders : NMD|July 6, 2011
Intragenic rearrangements in LARGE and POMGNT1 genes in severe dystroglycanopathiesS Vuillaumier-Barrot, C Bouchet-Seraphin, M Chelbi, et al.
Oncogene|January 29, 2014
SPRED1, a RAS MAPK pathway inhibitor that causes Legius syndrome, is a tumour suppressor downregulated in paediatric acute myeloblastic leukaemiaE Pasmant, B Gilbert-Dussardier, A Petit, et al.
Biorxiv : the Preprint Server for Biology|November 22, 2024
Neuropeptides specify and reprogram division of labor in the leafcutter ant <i>Atta cephalotes</i>Michael B Gilbert, Karl M Glastad, Maxxum Fioriti, et al.
Peerj|December 7, 2017
PlantCV v2: Image analysis software for high-throughput plant phenotypingMalia A Gehan, Noah Fahlgren, Arash Abbasi, et al.
Medrxiv : the Preprint Server for Health Sciences|September 21, 2021
Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine EvaluationYunda Huang, Oleg Borisov, Jia Jin Kee, et al.
Research Square|September 8, 2021
Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine EvaluationYunda Huang, Oleg Borisov, Jia Jin Kee, et al.
Plos One|July 21, 2017
Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adultsSusan P Buchbinder, Nicole A Grunenberg, Brittany J Sanchez, et al.
Human Vaccines & Immunotherapeutics|July 2, 2021
Prediction of serum HIV-1 neutralization titers of VRC01 in HIV-uninfected Antibody Mediated Prevention (AMP) trial participantsYunda Huang, Lily Zhang, Amanda Eaton, et al.
Plos Pathogens|March 15, 2021
Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection riskErica Andersen-Nissen, Andrew Fiore-Gartland, Lamar Ballweber Fleming, et al.
Viruses|September 28, 2024
Non-HIV Vaccine-Induced Immune Responses as Potential Baseline Immunogenicity Predictors of ALVAC-HIV and AIDSVAX B/E-Induced Immune ResponsesYing Huang, Shomoita Alam, Erica Andersen-Nissen, et al.
Pageof 87

Showing results (721-730 of 869) with videos related to

Sort By:
Pageof 87
Neuromuscular Disorders : NMD|July 6, 2011
Intragenic rearrangements in LARGE and POMGNT1 genes in severe dystroglycanopathiesS Vuillaumier-Barrot, C Bouchet-Seraphin, M Chelbi, et al.
Oncogene|January 29, 2014
SPRED1, a RAS MAPK pathway inhibitor that causes Legius syndrome, is a tumour suppressor downregulated in paediatric acute myeloblastic leukaemiaE Pasmant, B Gilbert-Dussardier, A Petit, et al.
Biorxiv : the Preprint Server for Biology|November 22, 2024
Neuropeptides specify and reprogram division of labor in the leafcutter ant <i>Atta cephalotes</i>Michael B Gilbert, Karl M Glastad, Maxxum Fioriti, et al.
Peerj|December 7, 2017
PlantCV v2: Image analysis software for high-throughput plant phenotypingMalia A Gehan, Noah Fahlgren, Arash Abbasi, et al.
Medrxiv : the Preprint Server for Health Sciences|September 21, 2021
Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine EvaluationYunda Huang, Oleg Borisov, Jia Jin Kee, et al.
Research Square|September 8, 2021
Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine EvaluationYunda Huang, Oleg Borisov, Jia Jin Kee, et al.
Plos One|July 21, 2017
Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adultsSusan P Buchbinder, Nicole A Grunenberg, Brittany J Sanchez, et al.
Human Vaccines & Immunotherapeutics|July 2, 2021
Prediction of serum HIV-1 neutralization titers of VRC01 in HIV-uninfected Antibody Mediated Prevention (AMP) trial participantsYunda Huang, Lily Zhang, Amanda Eaton, et al.
Plos Pathogens|March 15, 2021
Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection riskErica Andersen-Nissen, Andrew Fiore-Gartland, Lamar Ballweber Fleming, et al.
Viruses|September 28, 2024
Non-HIV Vaccine-Induced Immune Responses as Potential Baseline Immunogenicity Predictors of ALVAC-HIV and AIDSVAX B/E-Induced Immune ResponsesYing Huang, Shomoita Alam, Erica Andersen-Nissen, et al.
Pageof 87